Correction of Coagulopathy in the Setting of Acute Liver Failure

Critical Care Nursing Clinics of North America

Volumn 22, Issue 3, 2010, Pages 315-321

  Mahajan, Amit ^a   Lat, Ishaq ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Acute liver failure; Bleeding; Coagulopathy; Hemorrhage

Indexed keywords

EID: 77955324843     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccell.2010.02.001     Document Type: Review

References (23)

1. Ghany M., Hoofnagle JH. Approach to the patient with liver disease. Harrison's principles of internal medicine 2005, 1808-1813. McGraw-Hill Companies, New York. 16th edition. D.L. Kasper, E. Braunwald, A.S. Fauci (Eds.).
2. Greenberg D.L., Davie E.W. Blood coagulation factors: their complementary DNAs, genes, and expression. Hemostsis & thrombosis: basic principles and clinical practice. 4th edition 2001, 21-27. Lippincott, Williams & Wilkins, Philadelphia. R.W. Coleman, J. Hirsh, V.J. Marder (Eds.).
3. Schiodt F.V., Balko J., Schilsky M., et al. Thrombopoietin in acute liver failure. Hepatology 2003, 37:558-561.
4. Pereira L.M., Langley P.G., Hayllar K.M., et al. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators. Gut 1992, 33:98-102.
5. Hugenholt G.C., Porte R.J., Lisman T. The platelet and platelet function testing in liver disease. Clin Liver Dis 2009, 13:11-20.
6. Lisman T., Leebeek F.W. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg 2007, 24:250-258.
7. Cook D.J., Fuller H.D., Guyatt G.H., et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994, 330:377-381.
8. Bailey R., MacDougall B., Williams R. A controlled trial of the H2-receptor antagonists in prophylaxis of bleeding from gastrointestinal tract erosions in fulminant hepatic failure. Gut 1976, 17:389.
9. MacDougall B., Bailey R., Williams R. H2-Receptor antagonists and antacids in the presentation of acute upper gastrointestinal haemorrhage in fulminant hepatic failure. Lancet 1977, 1:617-619.
10. Polson J., Lee W.M. AASLD position paper: the management of acute liver failure. Hepatology 2005, 41:1179-1197.
11. Stravitz R.T., Kramer A.H., Davern T. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med 2007, 35:2498-2508.
12. Blei A.T., Olafsson S., Webster S., et al. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993, 341:157-158.
13. O'Grady J.G., Langley P.G., Isola L.M., et al. Coagulopathy of fulminant hepatic failure. Semin Liver Dis 1986, 6:159-163.
14. Guimond J., Pinsky M., Matuschak G. Effect of synchronous increase in intrathoracic pressure on cardiac performance during acute endotoxemia. J Appl Phys 1990, 69:1502-1508.
15. Pinsky M.R., Matuschak G., Bernardi L., et al. Effects of cardiac cycle-specific increases in intrathoracic pressure. J Appl Phys 1986, 60:604-612.
16. Sulek C.A., Blas M.L., Lobato E.B. A randomized study of left versus right internal jugular vein cannulation in adults. J Clin Anesth 2000, 12:142-145.
17. O'Grady J.G., Gimson A.E., O'Brien C.J., et al. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988, 94:1186-1192.
18. Jackson E.W., Zacks S., Zinn S., et al. Delayed neuropsychologic dysfunction after liver transplantation for acute liver failure: a matched, case-controlled study. Liver Transpl 2002, 8:932-936.
19. Donovan J.P., Shaw B.W., Langnas A.N., et al. Brain water and acute liver failure: the emerging role of intracranial pressure monitoring. Hepatology 1992, 16:267-268.
20. Hanid M., Davies M., Mellon P.J., et al. Clinical monitoring of intracranial pressure in fulminant hepatic failure. Gut 1980, 21:866-869.
21. Silk D.B., Trewby P.N., Chase R.A., et al. Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis. Lancet 1977, 2:1-3.
22. Munoz S.J., Ballas S.K., Moritz M.J., et al. Perioperative management of fulminant and subfulminant hepatic failure with therapeutic plasmapharesis. Transplant Proc 1989, 21:3535-3536.
23. Erber W.N., Perry D.J. Plasma and plasma products in the treatment of massive haemorrhage. Best Pract Res Clin Haematol 2006, 19:97-112.